Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors: Ren, Qian; Ma, Min; Yang, Jun; Nonaka, Risa; Yamaguchi, Akihiro; Ishikawa, Kei-Ichi; Kobayashi, Kenta; Murayama, Shigeo; Hwang, Sung Hee; Saiki, Shinji; Akamatsu, Wado; Hattori, Nobutaka; Hammock, Bruce D; Hashimoto, Kenji

Published In Proc Natl Acad Sci U S A, (2018 Jun 19)

Abstract: Parkinson's disease (PD) is characterized as a chronic and progressive neurodegenerative disorder, and the deposition of specific protein aggregates of α-synuclein, termed Lewy bodies, is evident in multiple brain regions of PD patients. Although there are several available medications to treat PD symptoms, these medications do not prevent the progression of the disease. Soluble epoxide hydrolase (sEH) plays a key role in inflammation associated with the pathogenesis of PD. Here we found that MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced neurotoxicity in the mouse striatum was attenuated by subsequent repeated administration of TPPU, a potent sEH inhibitor. Furthermore, deletion of the sEH gene protected against MPTP-induced neurotoxicity, while overexpression of sEH in the striatum significantly enhanced MPTP-induced neurotoxicity. Moreover, the expression of the sEH protein in the striatum from MPTP-treated mice or postmortem brain samples from patients with dementia of Lewy bodies (DLB) was significantly higher compared with control groups. Interestingly, there was a positive correlation between sEH expression and phosphorylation of α-synuclein in the striatum. Oxylipin analysis showed decreased levels of 8,9-epoxy-5Z,11Z,14Z-eicosatrienoic acid in the striatum of MPTP-treated mice, suggesting increased activity of sEH in this region. Interestingly, the expression of sEH mRNA in human PARK2 iPSC-derived neurons was higher than that of healthy control. Treatment with TPPU protected against apoptosis in human PARK2 iPSC-derived dopaminergic neurons. These findings suggest that increased activity of sEH in the striatum plays a key role in the pathogenesis of neurodegenerative disorders such as PD and DLB. Therefore, sEH may represent a promising therapeutic target for α-synuclein-related neurodegenerative disorders.

PubMed ID: 29735655 Exiting the NIEHS site

MeSH Terms: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacology; Animals; Cell Line; Corpus Striatum/metabolism; Corpus Striatum/pathology; Disease Models, Animal; Dopaminergic Neurons/drug effects; Dopaminergic Neurons/pathology; Epoxide Hydrolases/metabolism*; HEK293 Cells; Humans; Lewy Bodies/drug effects; Lewy Bodies/metabolism; Lewy Bodies/pathology; MPTP Poisoning/metabolism; MPTP Poisoning/pathology; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration/metabolism; Nerve Degeneration/pathology; Parkinson Disease/metabolism*; Parkinson Disease/pathology*; RNA, Messenger/metabolism; alpha-Synuclein/metabolism

Back
to Top